The Evaluation of Cow Milk-Based Formulas

Mead Johnson Nutrition

Status: Completed

Conditions: Term Infants

Treatments: Other: Marketed infant formula with DHA and ARA; Other: Milk-based infant formula with DHA and ARA; Other: Milk-based formula with DHA, ARA, prebiotics

Study type: Interventional

Funder types: Industry

Identifiers

NCT00518414

3378

Details and patient eligibility

About

Infants will be fed infant formula and blood drawn to measure fatty acid levels in the blood.

Enrollment: 136 patients

Sex: All

Ages: 10 to 18 days old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy, term infant
• 10 to 18 days of age

Exclusion criteria

• Breast fed infants
• Infants with formula intolerance

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

136 participants in 3 patient groups

Marketed infant formula with DHA and ARA

Active Comparator group

Description:

Marketed milk-based infant formula containing docosahexaenoic acid (DHA) and arachidonic acid (ARA)

Treatment:

Other: Marketed infant formula with DHA and ARA

Milk-based infant formula with DHA and ARA

Experimental group

Description:

Experimental milk-based infant formula containing docosahexaenoic acid (DHA) and arachidonic acid (ARA)

Treatment:

Other: Milk-based infant formula with DHA and ARA

Milk-based formula with DHA, ARA, prebiotics

Experimental group

Description:

Experimental milk-based infant formula containing docosahexaenoic acid (DHA) and arachidonic acid (ARA) and prebiotic blend

Treatment:

Other: Milk-based formula with DHA, ARA, prebiotics